Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:2800-2805
Published online before print November 4, 2002, doi: 10.1161/01.CIR.0000039528.49161.E9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/22/2800    most recent
01.CIR.0000039528.49161.E9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minuz, P.
Right arrow Articles by Patrono, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minuz, P.
Right arrow Articles by Patrono, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
*PROSTAGLANDIN F2ALPHA
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other etiology
Right arrow Oxidant stress

(Circulation. 2002;106:2800.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Increased Oxidative Stress and Platelet Activation in Patients With Hypertension and Renovascular Disease

Pietro Minuz, MD; Paola Patrignani, PhD; Stefania Gaino, MD; Maurizio Degan, BS; Laura Menapace, MD; Rosamaria Tommasoli, BS; Francesca Seta, DPharm; Marta L. Capone, DPharm; Stefania Tacconelli, DPharm; Simone Palatresi, MD; Chiara Bencini, MD; Cecilia Del Vecchio, MD; Giancarlo Mansueto, MD; Enrico Arosio, MD; Clara Lechi Santonastaso, MD; Alessandro Lechi, MD; Alberto Morganti, MD; Carlo Patrono, MD

From the Department of Biomedical and Surgical Sciences, University of Verona (P.M., S.G., M.D., L.M., R.T., G.M., E.A., C.L.S., A.L.); the Center of Excellence on Aging, "G. D’Annunzio" University of Chieti (P.P., F.S., M.L.C, S.T., C.P.); the Institute of Clinical Medicine and Physiology, University of Milan (S.P., C.B., C.D.V., A.M.); and the Department of Pharmacology, "La Sapienza" University of Rome (C.P.), Italy.

Correspondence to Pietro Minuz, MD, Medicina Interna C, Policlinico GB Rossi, 37134 Verona, Italy. E-mail pietro.minuz{at}mail.univr.it

Background— Hypertensive patients with renovascular disease (RVD) may be exposed to increased oxidative stress, possibly related to activation of the renin-angiotensin system.

Methods and Results— We measured the urinary excretion of 8-iso-prostaglandin (PG) F2{alpha} and 11-dehydro-thromboxane (TX) B2 as indexes of in vivo lipid peroxidation and platelet activation, respectively, in 25 patients with RVD, 25 patients with essential hypertension, and 25 healthy subjects. Plasma renin activity in peripheral and renal veins, angiotensin II in renal veins, cholesterol, glucose, triglycerides, homocysteine, and antioxidant vitamins A, C, and E were also determined. Patients were also studied 6 months after a technically successful angioplasty of the stenotic renal arteries. Urinary 8-iso-PGF2{alpha} was significantly higher in patients with RVD (median, 305 pg/mg creatinine; range, 124 to 1224 pg/mg creatinine) than in patients with essential hypertension (median, 176 pg/mg creatinine; range, 48 to 384 pg/mg creatinine) or in healthy subjects (median, 123 pg/mg creatinine; range, 58 to 385 pg/mg creatinine). Urinary 11-dehydro-TXB2 was also significantly higher in RVD patients compared with healthy subjects. In RVD patients, urinary 8-iso-PGF2{alpha} correlated with 11-dehydro-TXB2 (rs=0.48; P<0.05) and renal vein renin (rs=0.67; P<0.005) and angiotensin II (rs=0.65; P=0.005) ratios. A reduction in 8-iso-PGF2{alpha} after angioplasty was observed in RVD patients with high baseline levels of lipid peroxidation. Changes in 8-iso-PGF2{alpha} were related to baseline lipid peroxidation (rs=-0.73; P<0.001), renal vein angiotensin II (rs=-0.70; P<0.01) and renin (rs=-0.63; P<0.05) ratios.

Conclusions— Lipid peroxidation is markedly enhanced in hypertensive patients with RVD and is related to activation of the renin-angiotensin system. Moreover, persistent platelet activation triggered or amplified by bioactive isoprostanes may contribute to the progression of cardiovascular and renal damage in this setting.


Key Words: thromboxane • stenosis • hypertension • renin • angiotensin




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
A. Karagiannis, K. Tziomalos, P. Anagnostis, T. Gossios, and V. G. Athyros
Atherosclerotic Renal Artery Stenosis: Medical Therapy Alone or in Combination With Revascularization?
Angiology, August 1, 2009; 60(4): 397 - 402.
[PDF]


Home page
HypertensionHome page
R. Pedrosa, V. A. M. Villar, A. M. Pascua, S. Simao, U. Hopfer, P. A. Jose, and P. Soares-da-Silva
H2O2 Stimulation of the Cl-/HCO3- Exchanger by Angiotensin II and Angiotensin II Type 1 Receptor Distribution in Membrane Microdomains
Hypertension, May 1, 2008; 51(5): 1332 - 1338.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Bivol, R. K. Berge, and B. M. Iversen
Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R438 - R447.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ceriello
Possible Role of Oxidative Stress in the Pathogenesis of Hypertension
Diabetes Care, February 1, 2008; 31(Supplement_2): S181 - S184.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Lavi, E. H. Yang, A. Prasad, V. Mathew, G. W. Barsness, C. S. Rihal, L. O. Lerman, and A. Lerman
The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans
Hypertension, January 1, 2008; 51(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Davi and C. Patrono
Platelet Activation and Atherothrombosis
N. Engl. J. Med., December 13, 2007; 357(24): 2482 - 2494.
[Full Text] [PDF]


Home page
HypertensionHome page
D. G. Hackam, J. D. Spence, A. X. Garg, and S. C. Textor
Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension
Hypertension, December 1, 2007; 50(6): 998 - 1003.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. Wu, W. C. Willett, N. Rifai, and E. B. Rimm
Plasma Fluorescent Oxidation Products as Potential Markers of Oxidative Stress for Epidemiologic Studies
Am. J. Epidemiol., September 1, 2007; 166(5): 552 - 560.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Djamali
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F445 - F455.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M. Luther, J. V. Gainer, L. J. Murphey, C. Yu, D. E. Vaughan, J. D. Morrow, and N. J. Brown
Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor-Dependent Mechanism
Hypertension, December 1, 2006; 48(6): 1050 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. D. Morrow
Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Davi, M. Neri, A. Falco, D. Festi, T. Taraborelli, G. Ciabattoni, S. Basili, F. Cuccurullo, and C. Patrono
Helicobacter Pylori Infection Causes Persistent Platelet Activation In Vivo Through Enhanced Lipid Peroxidation
Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 246 - 251.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. MONTUSCHI, P. J. BARNES, and L. J. ROBERTS II
Isoprostanes: markers and mediators of oxidative stress
FASEB J, December 1, 2004; 18(15): 1791 - 1800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Adler and H. Huang
Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase
Am J Physiol Renal Physiol, November 1, 2004; 287(5): F907 - F913.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Krotz, H.-Y. Sohn, and U. Pohl
Reactive Oxygen Species: Players in the Platelet Game
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Schwedhelm, A. Bartling, H. Lenzen, D. Tsikas, R. Maas, J. Brummer, F.-M. Gutzki, J. Berger, J. C. Frolich, and R. H. Boger
Urinary 8-iso-Prostaglandin F2{alpha} as a Risk Marker in Patients With Coronary Heart Disease: A Matched Case-Control Study
Circulation, February 24, 2004; 109(7): 843 - 848.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Galinanes and A. G Fowler
Role of clinical pathologies in myocardial injury following ischaemia and reperfusion
Cardiovasc Res, February 15, 2004; 61(3): 512 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Adler, H. Huang, M. S. Wolin, and P. M. Kaminski
Oxidant Stress Leads to Impaired Regulation of Renal Cortical Oxygen Consumption by Nitric Oxide in the Aging Kidney
J. Am. Soc. Nephrol., January 1, 2004; 15(1): 52 - 60.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Minuz, P. Patrignani, S. Gaino, F. Seta, M. L. Capone, S. Tacconelli, M. Degan, G. Faccini, A. Fornasiero, G. Talamini, et al.
Determinants of Platelet Activation in Human Essential Hypertension
Hypertension, January 1, 2004; 43(1): 64 - 70.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Taniyama and K. K. Griendling
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Hypertension, December 1, 2003; 42(6): 1075 - 1081.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ritz and V. Haxsen
Angiotensin II and Oxidative Stress: An Unholy Alliance
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2985 - 2987.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Fujii, L. Zhang, J. Igarashi, and H. Kosaka
L-Arginine Reverses p47phox and gp91phox Expression Induced by High Salt in Dahl Rats
Hypertension, November 1, 2003; 42(5): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. K. Griendling and G. A. FitzGerald
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Circulation, October 28, 2003; 108(17): 2034 - 2040.
[Full Text] [PDF]


Home page
CirculationHome page
G. Davi, F. Chiarelli, F. Santilli, M. Pomilio, S. Vigneri, A. Falco, S. Basili, G. Ciabattoni, and C. Patrono
Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus: Role of Interleukin-6 and Disease Duration
Circulation, July 1, 2003; 107(25): 3199 - 3203.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-L. Cracowski, J.-P. Baguet, P. Minuz, S. Gaino, M. Degan, L. Menapace, R. Tommasoli, G. Mansueto, E. Arosio, C. L. Santonastaso, et al.
Isoprostanes: Are They More Than Physiopathological Biomarkers of Lipid Peroxidation? * Response
Circulation, June 24, 2003; 107 (24): e222 - e222.
[Full Text] [PDF]